Clinical update: cyanotic adult congenital heart disease

Lancet

Volumn 370, Issue 9598, 2007, Pages 1530-1532

  Spence, Mark S ^a,b   Balaratnam, Michelle S ^a   Gatzoulis, Michael A ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b ROYAL JUBILEE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD VISCOSITY; CONGENITAL HEART DISEASE; CYANOSIS; ERYTHROCYTE COUNT; ERYTHROCYTOSIS; HUMAN; IRON DEFICIENCY; OXYGEN SATURATION; PHLEBOTOMY; PRIORITY JOURNAL;

EID: 35648944207     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61647-X     Document Type: Note

References (20)

1. Brickner M., Hillis L., and Lange R. Congenital heart disease in adults. N Engl J Med 342 (2000) 256-263
2. Moller J., Taubert K., Allen H., et al. Cardiovascular health and disease in children: current status. Circulation 89 (1994) 923-930
3. Warnes C., Liberthson R., Danielson G., et al. The changing profile of congenital heart disease in adult life. J Am Coll Cardiol 37 (2001) 1170-1175
4. Wren C., and O'Sullivan J. Survival with congenital heart disease and need for follow up in adult life. Heart 85 (2001) 438-443
5. Perloff J., and Warnes C. Challenges posed by adults with repaired CHD. Circulation 103 (2001) 2637-2643
6. Niwa K., Perloff J., and Webb G. Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol 96 (2004) 211-216
7. Rosove M., Hocking W., Child J., et al. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet 2 (1986) 313-315
8. Ammash N., and Warnes C. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 28 (1996) 768-772
9. Thorne S. Management of polycythemia in adults with cyanotic congenital heart disease. Heart 79 (1998) 315-316
10. Diller G., and Gatzoulis M. Pulmonary vascular disease in adults with congenital heart disease. Circulation 115 (2007) 1051-1058
11. Oechslin E. Eisenmenger's syndrome. In: Gatzoulis M., Webb G., and Daubeney P. (Eds). Diagnosis and management of adult congenital heart disease (2003), Churchill Livingstone, Philadelphia, PA, USA 363-378
12. Diller G., Dimopoulos K., Broberg C., et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 27 (2006) 1737-1742
13. Dedkov E., Perloff J., Tomanek R., et al. The coronary microcirculation in cyanotic congenital heart disease. Circulation 114 (2006) 196-200
14. Fairbanks V., and Beutler E. Iron deficiency. In: Beutler E., Lichtman M., Coller B., Kipps T., and Seligsohn U. (Eds). Williams haematology. 5th edn. (1995), McGraw Hill, New York, USA 490-511
15. Milligan D., MacNamee R., Roberts B., et al. The influence of iron-deficient indices on whole blood viscosity in polycythaemia. Br J Haematol 50 (1982) 467-471
16. Broberg C., Bax B., Okonko D., et al. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol 48 (2006) 356-365
17. Katayama Y., Horigome H., Murakami T., et al. Evaluation of blood rheology in patients with cyanotic congenital heart disease using a microchannel array flow analyzer. Clin Hemorheol Microcirc 35 (2006) 499-508
18. Kaemmerer H., Fratz S., Braun S., et al. Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital cardiac disease. Am J Cardiol 94 (2004) 825-828
19. Berk P., Goldberg J., Donovan P., et al. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol 23 (1986) 132-143
20. Perloff J., Marelli A., and Miner P. Risk of stroke in adults with cyanotic congenital heart disease. Circulation 87 (1993) 1954-1959